Ligand validation:3T2V

TLA: L(+)-TARTARIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3T2V_TLA_C_172	45%	19%	0.19	0.921	1.43	2.02	2	5	1	0	100%	0.9
3C2X_TLA_C_6748	80%	27%	0.09	0.939	1.55	1.38	2	3	0	0	100%	1
7DY5_TLA_D_201	78%	41%	0.121	0.965	0.99	1.29	-	2	0	0	100%	1
3NNO_TLA_C_172	73%	31%	0.136	0.963	0.95	1.77	-	4	1	0	100%	0.95
7XFW_TLA_C_201	70%	39%	0.13	0.949	1.19	1.18	1	2	1	0	100%	1
7XFX_TLA_C_201	70%	37%	0.139	0.956	1.23	1.26	-	2	0	0	100%	1
2BLR_TLA_A_1207	100%	32%	0.023	0.994	1.77	0.94	2	-	0	0	100%	1
3WOU_TLA_A_302	100%	45%	0.029	0.996	1.18	0.96	-	-	0	0	100%	1
2VI4_TLA_A_1207	100%	41%	0.029	0.994	1.41	0.88	1	-	0	0	100%	1
3AL7_TLA_A_220	100%	43%	0.033	0.997	1.44	0.78	1	-	0	0	100%	1
5YYP_TLA_A_301	100%	26%	0.032	0.996	1.6	1.38	2	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.